Skip to main content

Mistrial Announced In Ethicon's TVM Lawsuit by Philly Jury

Mistrial Announced In Ethicon's TVM Lawsuit by Philly Jury

Mistrial Announced In Ethicon's TVM Lawsuit by Philly Jury

Introduction

The seventh transvaginal mesh trial in the Philadelphia Court of Common Pleas concluded with the jury declaring a deadlock in the case involving healthcare giant Johnson & Johnson (Ethicon) following four days of deliberation. The trial which began on August 27 ended with the mistrial announcement by Judge Michael Erdos.

The plaintiff, aged 67, was implanted with a Tension Free Vaginal Tape-Obturator system (TVT-O) on April 3, 2008. In subsequent days she experienced vaginal pain, urinary tract infections, vaginal bleeding, and dyspareunia. She underwent revision surgery on September 29, 2009, when her surgeon removed “very tight adhesions of the tension-free vaginal tape on the right periurethral area” and “trimmed” the TVT-O. However, she continued to experience severe complications due to the mesh implant. This is the first trial linked to TVT-O polypropylene mesh design defects.

Lawsuits filed against Ethicon Pelvic Mesh claiming design defect complications and failure to warn allegations are centralized as a part of a multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) overlooked by U.S. District Judge Joseph R. Goodwin in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.